Usher综合征人工耳蜗植入的长期效果
这项回顾性观察性队列研究纳入36例(53耳)Usher综合征人工耳蜗植入者,分早期植入USH1、晚期植入USH1、USH2和USH3四组,评估植入后1年、≥2年及≥5年的65 dB SPL音素识别得分。早期植入USH1长期音素得分达100%(IQR=95–100),USH2长期平均85%(IQR=81–95),USH3平均71%(IQR=45–91);USH1早期同期双侧植入效果优于序贯植入(p=0.028)。
要点
- 早期植入USH1(≤7岁)长期音素得分100%(IQR=95–100),植入年龄越小效果越好。
- 同期双侧植入USH1效果显著优于序贯植入(p=0.028)。
- USH2长期平均音素得分85%(IQR=81–95),USH3平均71%(IQR=45–91)。
核心结论
- Usher综合征患者整体在短期和长期随访中均从人工耳蜗植入获益。
- USH1早期同期双侧植入可望获得最佳效果;晚期植入仅提供声音信号功能,言语识别不足以进行口语交流。
- USH2和USH3可望获得良好效果,尤其当患者助听器言语识别充分且植入前有充足听觉刺激时。
- 作者建议USH2早期植入,因听力损失呈进展性且伴严重视觉损害;USH3因表型变异大,效果预测仍具挑战。
- 对USH2和USH3的咨询应强调早期植入获益并鼓励使用助听器。
研究设计与样本
- 回顾性观察性队列研究,纳入36例人工耳蜗植入者共53耳。
- 分为四组:早期植入USH1(首次植入≤7岁)、晚期植入USH1(首次植入≥8岁)、USH2和USH3。
- 在植入后1年、≥2年(中期)和≥5年(长期)评估65 dB SPL下人工耳蜗助听的音素得分。
主要发现
- 早期植入USH1组(N=23耳)长期音素得分100%(IQR=95–100),植入年龄越小与更好效果显著相关。
- 同期植入者效果显著优于序贯植入者(p=0.028)。
- 晚期植入USH1组(N=3耳)仅用于声音检测,平均音素识别得分12%(IQR=0–12),但对环境声检测表示满意。
- USH2组(N=23耳)长期平均音素得分85%(IQR=81–95),植入年龄越小和术前言语感知得分越高与更好效果相关。
- USH3组(N=7耳)植入后平均音素得分71%(IQR=45–91)。
关键数值与推荐
- 早期植入USH1组长期音素得分100%(IQR=95–100)。
- 晚期植入USH1组平均音素识别得分12%(IQR=0–12)。
- USH2组长期平均音素得分85%(IQR=81–95)。
- USH3组植入后平均音素得分71%(IQR=45–91)。
- 同期植入优于序贯植入(p=0.028)。
临床怎么用
- USH1患者可望通过早期同期双侧植入获得最佳人工耳蜗效果。
- USH1晚期植入可提供声音信号功能,但言语识别不足以进行口语交流。
- USH2和USH3患者可望获得良好人工耳蜗效果,尤其当助听器言语识别充分且植入前有充足听觉刺激时。
- 作者建议USH2早期植入;对USH2和USH3的咨询应强调早期植入获益并鼓励使用助听器。
局限性
- 三种亚型间表型变异大,各亚型分别分析导致样本量较小。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Usher syndrome (USH), characterized by bilateral sensorineural hearing loss (SNHL) and retinitis pigmentosa (RP), prompts increased reliance on hearing due to progressive visual deterioration. It can be categorized into three subtypes: USH type 1 (USH1), characterized by severe to profound congenital SNHL, childhood-onset RP, and vestibular areflexia; USH type 2 (USH2), presenting with moderate to severe progressive SNHL and RP onset in the second decade, with or without vestibular dysfunction; and USH type 3 (USH3), featuring variable progressive SNHL beginning in childhood, variable RP onset, and diverse vestibular function. Previous studies evaluating cochlear implant (CI) outcomes in individuals with USH used varying or short follow-up durations, while others did not evaluate outcomes for each subtype separately. This study evaluates long-term CI performance in subjects with USH, at both short-term and long-term, considering each subtype separately. DESIGN: This retrospective, observational cohort study identified 36 CI recipients (53 ears) who were categorized into four different groups: early-implanted USH1 (first CI at ≤7 years of age), late-implanted USH1 (first CI at ≥8 years of age), USH2 and USH3. Phoneme scores at 65 dB SPL with CI were evaluated at 1 year, ≥2 years (mid-term), and ≥5 years postimplantation (long-term). Each subtype was analyzed separately due to the significant variability in phenotype observed among the three subtypes. RESULTS: Early-implanted USH1-subjects (N = 23 ears) achieved excellent long-term phoneme scores (100% [interquartile ranges {IQR} = 95 to 100]), with younger age at implantation significantly correlating with better CI outcomes. Simultaneously implanted subjects had significantly better outcomes than sequentially implanted subjects ( p = 0.028). Late-implanted USH1 subjects (N = 3 ears) used CI solely for sound detection and showed a mean phoneme discrimination score of 12% (IQR = 0 to 12), while still expressing satisfaction with ambient sound detection. In the USH2 group (N = 23 ears), a long-term mean phoneme score of 85% (IQR = 81 to 95) was found. Better outcomes were associated with younger age at implantation and higher preimplantation speech perception scores. USH3-subjects (N = 7 ears) achieved a mean postimplantation phoneme score of 71% (IQR = 45 to 91). CONCLUSIONS: This study is currently one of the largest and most comprehensive studies evaluating CI outcomes in individuals with USH, demonstrating that overall, individuals with USH benefit from CI at both short- and long-term follow-up. Due to the considerable variability in phenotype observed among the three subtypes, each subtype was analyzed separately, resulting in smaller sample sizes. For USH1 subjects, optimal CI outcomes are expected with early simultaneous bilateral implantation. Late implantation in USH1 provides signaling function, but achieved speech recognition is insufficient for oral communication. In USH2 and USH3, favorable CI outcomes are expected, especially if individuals exhibit sufficient speech recognition with hearing aids and receive ample auditory stimulation preimplantation. Early implantation is recommended for USH2, given the progressive nature of hearing loss and concomitant severe visual impairment. In comparison with USH2, predicting outcomes in USH3 remains challenging due to the variability found. Counseling for USH2 and USH3 should highlight early implantation benefits and encourage hearing aid use.
引用
- Fehrmann MLA, Lanting CP, Haer-Wigman L, et al. Long-Term Outcomes of Cochlear Implantation in Usher Syndrome. Ear Hear. 2024. PMID: 38987893. doi:10.1097/AUD.0000000000001544
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。